Top Stories
The automated insulin delivery system was originally cleared for type 1 diabetes in 2024.
The tool developed by researchers at the University of Technology Sydney could support more personalised assessments and treatment.
OPKO had kept 4Kscore when it sold its BioReference oncology testing operations last year.
A research consortium will investigate how contactless hospital monitoring and at-home ECGs could be incorporated into routine cardiac care across Europe
The two funds will invest in biopharmas, medical device and diagnostic developers, and tech-forward healthcare service providers.
Conference News
Research strengthens the evidence for exome and genome sequencing as standard of care across rare disease, autism, newborn screening and beyondGAITHERSBURG, Md.--(BUSINESS WIRE)-- GeneDx, the leader i...
LOUISVILLE, Colo., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc (NASDAQ: BDSX), a leader in diagnostic solutions, today announced that the American College of Chest Physicians (CHEST) has published...
LEXINGTON, Mass.--(BUSINESS WIRE)-- FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, today announced that the new EB-840S and EB-840T bron...
SAN FRANCISCO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies (“ProSomnus”), the pioneer and global leader in Smart Sleep Medicine™, today announced the formation of its inaugural Medi...
PALO ALTO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- At the American Society of Human Genetics (ASHG) 2026 Annual Meeting, taking place October 20–24 in Montréal, 23andMe Research Institute will prese...
